The investment analyst J Capital issued a report on August 11, 2020 on STAAR entitled “STAAR Surgical, Less Than Meets the Eye.” It was alleged in the The J Capital report that the company overstated its sales in China by at least one third (or $21.6 mln), “meaning all of the company’s $14 mln in 2019 profit is fake.” The J Capital report – which was based on over 75 interviews with former employees, and extensive review of public documents, and site visits to China and Switzerland – concludes STAAR reports fake sales revenues by overstating sales and then marking up actual marketing costs to hide “phantom” revenue. The report found, in particular, that Aier Eye Hospital’s financial statements indicate that it bought only about half as many lenses as STAAR reports.
On August 11, 2020, STAAR’s stock price fell $3.17 per share, or 6%, on this news, to close at $48.25 per share, damaging investors.
Staar Surgical Company
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to firstname.lastname@example.org.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at email@example.com.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
8240 Beverly Blvd., Suite 9
Los Angeles, CA 90048